Neurological diseases are caused by complex interactions between many genes. Many drug discoveries fail because researchers target only one gene at a time. Using the same breakthroughs that power Google’s search engines, we’ve discovered a way to map out the hundreds of genes that cause a disease, and then find drugs that target all the genes at once.
Neurodegenerative diseases represent a growing global crisis. The current estimated cost to society is over $650 billion worldwide, and projected to reach over $1 trillion per year by 2020. Currently, no treatments prevent or stop the progression of the major neurodegenerative diseases.
In the past, most neuroscientists did not have the tools to disentangle the complex genetics of these diseases. Accelerating advances in human genomics, combined with recent insights into neurobiology, have created an unprecedented opportunity for the discovery of breakthrough treatments in the central nervous system (CNS). Our platform is specifically designed for neurological diseases, and can analyze thousands of datasets to identify new targets, predict effective drugs, and stratify patient subpopulations. Verge's genomic network approach offers a breakthrough opportunity to identify drugs that dramatically improve patient outcomes and fundamentally bend the cost curve of pharmaceutical development.
San Francisco, June 9, 2017
San Francisco, January 8, 2016
TechCrunch, November 3, 2015
BioWorld Today, October 29, 2015
San Francisco, October 28, 2015